PBD-150 is a potent small molecule inhibitor of the human glutaminyl cyclase (hQC) Y115E-Y117E mutant, exhibiting an inhibition constant (Ki) of 490 nM. This compound is a valuable research tool for investigating hQCs role in vitro, particularly in studies related to neurodegenerative conditions where QC activity is implicated.